The field of bioactive nanomaterials is reshaping the biomedical landscape by providing precise solutions for disease diagnosis and treatment. These materials, known for their exceptional physicochemical properties, enable targeted approaches to diseased tissues, enhancing therapeutic outcomes and reducing side effects. Recent advancements have led to the development of multifunctional systems that can deliver drugs, imaging agents, and therapeutic molecules concurrently, offering integrated diagnostic and therapeutic solutions. As diseases such as cancer, chronic illnesses, and infections continue to impose a global health burden, bioactive nanomaterials are at the forefront of research, exploring avant-garde solutions for the next generation of healthcare.

This Research Topic aims to explore the various challenges and opportunities in employing bioactive nanomaterials for disease diagnosis and treatment. It will spotlight innovative designs and strategies that enhance the functionality and efficacy of these materials, addressing the gap between their potential and clinical application. Despite promising developments, the translation of bioactive nanomaterials into clinical settings is often impeded by safety concerns, scalability issues, and stringent regulatory barriers. By assembling pioneering research and expert reviews, this topic will provide a detailed overview of the state-of-the-art, pinpointing critical directions for future research.

To gather further insights within the boundaries of bioactive nanomaterial applications, we welcome articles addressing, but not limited to, the following themes:

New techniques for nanomaterial fabrication

Targeted drug delivery systems

Advanced theranostic strategies

Bioactive technologies for clinical applications

Challenges in the clinical translation of nanomaterials

Regulatory and commercialization perspectives in nanotechnology

We invite contributions from a variety of disciplines, such as nanotechnology, pharmacology, materials science, and medicine, encouraging a multidisciplinary discussion that enhances our understanding and integration of bioactive nanomaterials into effective disease management strategies.

Please note:

Studies need to comply with the best practice guidelines of the leading journals for pharmacological studies on plant extract / natural products, including the Four Pillars of Best Practice in Ethnopharmacology, and follow the standards established in the ConPhyMP statement Front. Pharmacol. 13:953205. A detailed description of the material studied, its extraction, and processing is essential, and manuscripts that lack such a description will be desk-rejected. You can freely download the full version here (https://ga-online.org/best-practice). Please self-assess your MS using the ConPhyMP tool.
Purely in silico studies are outside of the scope of this journal (e.g., network studies)

Are you interested in contributing a manuscript to this Research Topic?

Advancements in Bioactive Nanomaterials for Disease Management

Topic Coordinator